Librela

Page contents

Overview
Product information
Product details
Authorisation details
Assessment history
News on Librela
Topics

Application under evaluation
CVMP opinion
European Commission decision

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Librela : EPAR - Medicine overview

Reference Number: EMA/518254/2020

English (EN) (81.94 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Other languages (25)

български (BG) (93.36 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

español (ES) (81.97 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

čeština (CS) (93.99 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

dansk (DA) (83.34 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Deutsch (DE) (82.76 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

eesti keel (ET) (82.18 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

ελληνικά (EL) (93.76 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

français (FR) (82.44 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

hrvatski (HR) (92.27 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

íslenska (IS) (83.29 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Gaeilge (GA) (83.57 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

italiano (IT) (82.29 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

latviešu valoda (LV) (94.29 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

lietuvių kalba (LT) (94.03 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

magyar (HU) (94.15 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Malti (MT) (95.95 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Nederlands (NL) (82.05 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

norsk (NO) (82 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

polski (PL) (95.62 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

português (PT) (83.01 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

română (RO) (94.17 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

slovenčina (SK) (94.08 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

slovenščina (SL) (82.27 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Suomi (FI) (81.54 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

svenska (SV) (82.05 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Product information

Librela : EPAR - Product information

English (EN) (81.49 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Other languages (25)

български (BG) (91.78 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

español (ES) (81.51 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

čeština (CS) (92.48 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

dansk (DA) (82.05 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Deutsch (DE) (81.72 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

eesti keel (ET) (81.22 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

ελληνικά (EL) (91.79 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

français (FR) (81.63 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

hrvatski (HR) (91.56 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

íslenska (IS) (81.52 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Gaeilge (GA) (81.36 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

italiano (IT) (81.76 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

latviešu valoda (LV) (92.14 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

lietuvių kalba (LT) (92.19 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

magyar (HU) (92.76 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Malti (MT) (93.86 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Nederlands (NL) (81.15 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

norsk (NO) (81.52 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

polski (PL) (93.22 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

português (PT) (82.53 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

română (RO) (91.73 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

slovenčina (SK) (81.75 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

slovenščina (SL) (81.76 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Suomi (FI) (81.11 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

svenska (SV) (81.47 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Librela : EPAR - All authorised presentations

English (EN) (81.94 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Other languages (25)

български (BG) (93.36 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

español (ES) (81.97 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

čeština (CS) (93.99 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

dansk (DA) (83.34 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Deutsch (DE) (82.76 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

eesti keel (ET) (82.18 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

ελληνικά (EL) (93.76 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

français (FR) (82.44 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

hrvatski (HR) (92.27 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

íslenska (IS) (83.29 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Gaeilge (GA) (83.57 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

italiano (IT) (82.29 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

latviešu valoda (LV) (94.29 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

lietuvių kalba (LT) (94.03 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

magyar (HU) (94.15 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Malti (MT) (95.95 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Nederlands (NL) (82.05 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

norsk (NO) (82 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

polski (PL) (95.62 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

português (PT) (83.01 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

română (RO) (94.17 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

slovenčina (SK) (94.08 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

slovenščina (SL) (82.27 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Suomi (FI) (81.54 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

svenska (SV) (82.05 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

Product details

Name of medicine: Librela
Active substance: bedinvetmab
International non-proprietary name (INN) or common name: bedinvetmab

Pharmacotherapeutic group

Other analgesics and antipyretics
bedinvetmab

Authorisation details

EMA product number: EMEA/V/C/005180
Opinion adopted: 09/09/2020

Assessment history

Librela : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (81.94 KB - PDF)

First published: 21/02/2022Last updated: 31/05/2024

View

Librela : EPAR - Public assessment report

Adopted

English (EN) (81.49 KB - PDF)

First published: 06/05/2021Last updated: 31/05/2024

View

CVMP summary of positive opinion for Librela

AdoptedReference Number: EMA/CVMP/438128/2020

English (EN) (133.73 KB - PDF)

First published: 11/09/2020

View

News on Librela

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-14 February 2024

16/02/2024

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 May 2023

22/05/2023

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 2023

17/02/2023

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 2023

17/02/2023

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-10 November 2022

11/11/2022

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 May 2022

13/05/2022

Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 13-15 July 2021

16/07/2021

Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 8-9 September 2020

11/09/2020

Topics

Medicines

This page was last updated on 31/05/2024

Authorised

Overview

Product information

Product details

Pharmacotherapeutic group

Authorisation details

Assessment history

Changes since initial authorisation of medicine

Initial marketing authorisation documents

News on Librela

Topics

Share this page